MK-677 vs HGH
Oral GH Secretagogue vs. Direct Growth Hormone: Which is Right for You?
MK-677 (ibutamoren) and HGH (somatropin) both elevate IGF-1 and produce growth hormone-related benefits — but through entirely different mechanisms, at vastly different costs, and with different legal and safety profiles. This guide breaks down every key difference to help you make an informed decision with your physician.
Full Comparison Table
| Feature | MK-677 (Ibutamoren) | HGH (Somatropin) |
|---|---|---|
| Form | Oral capsule/liquid | Subcutaneous injection |
| Administration | Once daily (oral) | Daily SQ injection (or 5-on-2-off) |
| Cost/month | ~$50–150 (research compound) | $800–$2,000+ (pharma US); cheaper overseas |
| IGF-1 Effect | 30–60% increase from baseline (dose-dependent) | Larger, more controllable; depends on dose |
| Mechanism | Ghrelin receptor agonist → stimulates pituitary GH | Direct GH replacement |
| Pituitary Suppression | None — preserves natural axis | Progressive suppression over time |
| Appetite Effect | Increased (ghrelin mimicry) | Minimal direct effect on appetite |
| Water Retention | Common, especially early on | Dose-dependent; higher at 2–4 IU/day |
| Legal Status (US) | Unscheduled research chemical (no Rx needed) | Prescription required; Schedule III |
| Monitoring Needed | IGF-1 at 12 weeks; fasting glucose | IGF-1 every 3–6 months; glucose; full panel |
| PCT Required | No | No (but axis recovery takes time off-drug) |
Who Should Choose MK-677?
- ✓Peptide newcomers who want GH axis support without needles
- ✓Budget-conscious individuals (MK-677 is 10–20x cheaper than pharma HGH)
- ✓Users prioritizing sleep quality improvement as primary goal
- ✓Those who want IGF-1 support without pituitary suppression
- ✓Travelers or those with compliance concerns (no refrigeration needed)
Who Should Choose HGH?
- ✓Clinically diagnosed adult GH deficiency (low IGF-1 + stimulation test confirmed)
- ✓Older patients whose pituitary reserve has declined (secretagogues less effective)
- ✓Those seeking maximum, controllable IGF-1 elevation
- ✓Patients already on HGH therapy transitioning off peptide stacks
- ✓Physicians who need precise dose control for deficiency replacement
IGF-1 Response: What the Data Shows
Both MK-677 and HGH reliably raise IGF-1 — the downstream marker used to assess GH axis activity. The key differences are in the magnitude, predictability, and ceiling of the IGF-1 response.
- •MK-677 at 10mg: Typically raises IGF-1 by 20–30% from baseline. Sustained elevation due to once-daily dosing; not pulsatile. Well-documented in Phase 2 clinical trials.
- •MK-677 at 25mg: Raises IGF-1 by 40–60%. At this dose, some individuals approach or exceed the upper limit of the normal age-adjusted range, requiring monitoring.
- •HGH at 1 IU/day: Variable but typically produces a mid-to-upper normal IGF-1 response. More controllable via dose titration than MK-677.
- •HGH at 4 IU/day: Often produces supraphysiologic IGF-1 without careful monitoring. This dose range is associated with significantly higher side effect risk including carpal tunnel, insulin resistance, and joint pain.
Frequently Asked Questions
Is MK-677 as effective as HGH for raising IGF-1?
MK-677 raises IGF-1 by 30–60% depending on dose. HGH can produce a larger, more controllable rise — particularly at 2–4 IU/day. For borderline-low IGF-1 or longevity goals, MK-677 is often sufficient. For diagnosed GH deficiency, HGH is more potent and appropriate.
Does MK-677 suppress the pituitary like HGH does?
No. MK-677 stimulates the pituitary to release its own GH — the natural feedback loop remains intact. Exogenous HGH, by contrast, progressively suppresses pituitary GH output through negative feedback. No PCT is needed for MK-677.
What is the real cost difference between MK-677 and HGH?
MK-677 as a research compound costs approximately $50–150/month. Pharmaceutical HGH (Norditropin, Humatrope, etc.) costs $800–$2,000+ per month in the US without insurance. Compounded or overseas HGH is cheaper but carries quality and legal risks. MK-677 is dramatically more accessible.
Is MK-677 legal without a prescription?
In the US and most countries as of 2026, MK-677 is an unscheduled research chemical — no prescription is required. HGH is a Schedule III controlled substance in the US; a prescription is legally required to obtain it.